106 records matched your query
01519aam a2200337Ia 4500 001 AC9D28BEFE5F11E2B6A414D3DAD10320 003 SILO 005 20130806010419 006 m d f 007 cr an||||||||| 008 100301s2000 mdu s f000 0 eng d 035 $a (OCoLC)535199198 040 $a GPO $c GPO $d MvI $d SILO 043 $a n-us--- 074 $a 0499-T (online) 086 0 $a HE 20.4702:IN 8/2 245 00 $a Guidance for industry, q & a $h [electronic resource] : $b content and format of INDs for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products. 246 2 $a Guidance for industry, questions and answers 246 30 $a Content and format of INDs for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products 260 $a Rockville, MD : $b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : $c [2000] 300 $a 1 online resource ([4] p.) 500 $a "Pharmacology/toxicology." 500 $a "October 2000." 650 0 $a Medicine, Experimental 650 0 $a Biotechnology $x Research $z United States. 710 2 $a Center for Drug Evaluation and Research (U.S.) 710 2 $a Center for Biologics Evaluation and Research (U.S.) 856 40 $u http://purl.access.gpo.gov/GPO/LPS119805 941 $a 1 952 $l USUX851 $d 20160825054714.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=AC9D28BEFE5F11E2B6A414D3DAD10320Initiate Another SILO Locator Search